Test Cyp 200mg/Ml in Sesame Oil Mdv
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Labeling: Not Elsewhere Classified; The packaging states these are ophthalmic drops. However, they are manufactured as nasal drops and sterility cannot be assured.
CGMP Deviations
Lack of Assurance of Sterility
Failed Dissolution Specifications
Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.
Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.
Failed Impurities/Degradation Specifications
Presence of foreign matter
Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stability testing. The microbiological investigation identified the organism as a member of the Bacillus cereus group.